Synonyms: example 3 [US20210276949]
Compound class:
Synthetic organic
Comment: The chemical structure for oveporexton was obtained from WHO proposed INN list 131 (August 2024). The INN record describes the compound as an orexin type 2 receptor agonist. Structure match in patents suggests that this might be the INN for Takeda's clinical lead TAK-861, as it is one of the examples claimed in patent US20210276949A1 [1].
|
|
References |
1. Hattori Y, Miyanohana Y, Kajita Y, Koike T, Hoashi Y, Tokunaga N, Pawliczek AM, Oda T, Miyazaki T, Ito Y. (2021)
Heterocyclic compound and use thereof. Patent number: US20210276949A1. Assignee: Takeda Pharmaceutical Co Ltd. Priority date: 23/04/2021. Publication date: 09/09/2021. |